selumetinib

selumetinib
Trade Name
Orphan Indication Uveal melanoma
USA Market Approval USA
USA Designation Date 2015-04-15 00:00:00
Sponsor AstraZeneca Pharmaceuticals LP;1800 Concord Pike, P. O. Box 8355;Wilmington, Delaware, 19803